← Back to Patent Explorer
US4837312A Expired / Lapsed US ⏱️ 0.0 years remaining

Chelator-functionalized nucleosides and nucleotides and methods for making same

Assignee: California Institute of Technology
•
Filing: 1985-01-25
•
Granted: 1989-06-06
•
Expires: 2005-01-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Nucleosides and nucleotides functionalized with a metal chelator, and methods of synthesizing such nucleosides and nucleotides are described. These compounds are useful, for example, as constituents of nucleic acid probes for diagnostic and therapeutic purposes.

Inventors

  • 👤 Peter B. Dervan
  • 👤 Geoffrey B. Dreyer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 16:13
CPC Classifications
C; C07; C07H; C07H23/00; C07H21/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 168 words
A compound of structure: ##STR2## where Z is hydrogen or hydroxy; Y is NHR 1 , W where w is a hydroxyl protecting group or ##STR3## T is hydrogen or hydroxyl or ##STR4## where Q is OR 1 , R 1 or NHR 1 , or ##STR5## where V is OR 1 , R 1 or NHR 1 and where U is a polyribonucleotide or polydeoxyribonucleotide sequence; and where X is a nucleoside base selected from the group consisting of ##STR6## where R 1 is a thethered metal chelator said metal capable of reducing dioxygen; provided, however, that when Y is ##STR7## or NHR 1 , X is a nucleoside base selected from the group consisting of tethered metal chelator functionalized nucleoside bases guanine, adenine, cytosine, uracil and thymine, provided that when X is thymine, T is hydrogen; and provided that when T is ##STR8## X is a nucleoside base selected from the group consisting of tethered metal chelator functionalized nucleoside bases guanine, adenine, cytosine, uracil and thymine.
Claim 2
Dependent Claim 168 words
A compound of structure: ##STR2## where Z is hydrogen or hydroxy; Y is NHR 1 , W where w is a hydroxyl protecting group or ##STR3## T is hydrogen or hydroxyl or ##STR4## where Q is OR 1 , R 1 or NHR 1 , or ##STR5## where V is OR 1 , R 1 or NHR 1 and where U is a polyribonucleotide or polydeoxyribonucleotide sequence; and where X is a nucleoside base selected from the group consisting of ##STR6## where R 1 is a thethered metal chelator said metal capable of reducing dioxygen; provided, however, that when Y is ##STR7## or NHR 1 , X is a nucleoside base selected from the group consisting of tethered metal chelator functionalized nucleoside bases guanine, adenine, cytosine, uracil and thymine, provided that when X is thymine, T is hydrogen; and provided that when T is ##STR8## X is a nucleoside base selected from the group consisting of tethered metal chelator functionalized nucleoside bases guanine, adenine, cytosine, uracil and thymine.
Claim 3
Dependent Claim 53 words
A compound of structure ##STR9## where Z is hydrogen or hydroxyl; Y is hydroxyl or W where W is a hydroxyl-protecting group; T is hydroxyl and X is a nucleoside base selected from the group consisting of ##STR10## and where R 1 is a tethered metal chelator said metal capable of reducing dioxygen.
Claim 4
Dependent Claim 53 words
A compound of structure ##STR9## where Z is hydrogen or hydroxyl; Y is hydroxyl or W where W is a hydroxyl-protecting group; T is hydroxyl and X is a nucleoside base selected from the group consisting of ##STR10## and where R 1 is a tethered metal chelator said metal capable of reducing dioxygen.
Claim 5
Dependent Claim 16 words
The compound according to claim 1 or 2 wherein the hydroxyl protecting group is dimethoxytrityl chloride.
Claim 6
Dependent Claim 25 words
The compound according to claim 1 or 2 wherein said tether is a hydrocarbon-amide linkage and said metal chelator is a polyamino carboxylic acid chelator.
Claim 7
Dependent Claim 18 words
The compound according to claim 4 wherein said tether is the structure: ##STR11## and said chelator is EDTA.
Claim 8
Dependent Claim 23 words
The compound according to claim 4 wherein the metal chelator is selected from the group consisting of EDTA, DCTA, DTPA, EDDHA and HEEDTA.
Claim 9
Dependent Claim 6 words
The chelator-functionalized nucleoside of structure: ##STR12##
Claim 10
Dependent Claim 6 words
The chelator-functionalized nucleoside of structure: ##STR12##
Claim 11
Dependent Claim 6 words
The chelator-functionalized nucleoside of structure: ##STR13##
Claim 12
Dependent Claim 6 words
The chelator-functionalized nucleoside of structure: ##STR13##

References Cited (Backward Citations)

US4529796A Cited
US4665184A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-05 1992-12-05 1993-06-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-05 1996-12-05 1997-06-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-05 2000-12-05 2001-06-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag